Puma Biotechnology Shares Tumble +25%, Citi Remains Optimistic Despite 'Challenges'

By: via Benzinga
In a report published Sunday, Citi analyst Yaron Werber warns investors of upcoming challenges for Puma Biotechnology (NYSE: PBYI) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.